Karolinska Development AB (KDEVF)
0.2576
0.00 (0.00%)
USD |
OTCM |
Oct 28, 16:00
Karolinska Development Debt to Equity Ratio: 0.00 for June 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
Date | Value |
---|---|
June 30, 2024 | 0.00 |
March 31, 2024 | 0.00 |
December 31, 2023 | 0.00 |
September 30, 2023 | 0.00 |
June 30, 2023 | 0.00 |
March 31, 2023 | 0.00 |
December 31, 2022 | 0.00 |
September 30, 2022 | 0.00 |
June 30, 2022 | 0.00 |
March 31, 2022 | 0.00 |
December 31, 2021 | 0.1283 |
September 30, 2021 | 0.1238 |
June 30, 2021 | 0.0793 |
March 31, 2021 | 0.0996 |
December 31, 2020 | 0.0948 |
September 30, 2020 | 0.1042 |
June 30, 2020 | 0.0792 |
March 31, 2020 | 0.0794 |
December 31, 2019 | 0.0893 |
September 30, 2019 | 1.869 |
June 30, 2019 | 1.776 |
March 31, 2019 | 1.774 |
December 31, 2018 | 1.616 |
September 30, 2018 | 1.480 |
June 30, 2018 | 1.457 |
Date | Value |
---|---|
March 31, 2018 | 1.582 |
December 31, 2017 | 1.420 |
September 30, 2017 | 1.567 |
June 30, 2017 | 8.683 |
March 31, 2017 | 5.520 |
December 31, 2016 | 13.23 |
September 30, 2016 | 7.248 |
June 30, 2016 | 5.262 |
March 31, 2016 | 2.432 |
December 31, 2015 | 1.409 |
September 30, 2015 | 0.9176 |
June 30, 2015 | 0.8293 |
March 31, 2015 | 0.2183 |
December 31, 2014 | 0.0182 |
September 30, 2014 | 0.00 |
June 30, 2014 | 0.00 |
March 31, 2014 | 0.00 |
December 31, 2013 | 0.00 |
September 30, 2013 | 0.00 |
June 30, 2013 | 0.00 |
March 31, 2013 | 0.00 |
December 31, 2012 | 0.00 |
September 30, 2012 | 0.0011 |
June 30, 2012 | 0.0011 |
March 31, 2012 | 0.0011 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Mar 2022
0.1283
Maximum
Dec 2021
0.0462
Average
--
Median
Mar 2022
Debt to Equity Ratio Benchmarks
Abliva AB | -- |
Calliditas Therapeutics AB | 9.200 |
Oncopeptides AB | 0.8095 |
BioInvent International AB | 0.00 |
Hansa Biopharma AB | -2.947 |
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 117.25M |
Total Liabilities (Quarterly) | 1.264M |
Shareholders Equity (Quarterly) | 115.99M |
Current Ratio | 4.710 |